Variant report

Variant	rs12867032
Chromosome Location	chr13:30963923-30963924
allele	A/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr13:30963591..30965165-chr13:30969250..30971365,2	MCF-7	breast:
2	chr13:30944939..30947830-chr13:30963625..30965440,2	K562	blood:
3	chr13:30962704..30965120-chr13:30966548..30968829,2	MCF-7	breast:

Variant related genes	Relation type
ENSG00000238121	Chromatin interaction

Extended variants
information (count: 8 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:7)

rs_ID	r²[population]
rs12855287	0.94[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs35052580	0.93[EUR][1000 genomes]
rs35624900	1.00[AMR][1000 genomes];0.93[EUR][1000 genomes]
rs6490458	1.00[CEU][hapmap];0.95[EUR][1000 genomes]
rs6490459	1.00[CEU][hapmap];0.98[EUR][1000 genomes]
rs7986129	1.00[CEU][hapmap];0.98[EUR][1000 genomes]
rs9508721	1.00[CEU][hapmap];0.98[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:1 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv530602	chr13:30911025-31404272	Strong transcription Weak transcription Flanking Active TSS Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	66 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:72 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:30951400-30969400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr13:30951600-30964200	Weak transcription	Esophagus	oesophagus
3	chr13:30961600-30964200	Enhancers	Primary monocytes fromperipheralblood	blood
4	chr13:30962000-30964200	Enhancers	Monocytes-CD14+_RO01746	blood
5	chr13:30962200-30964000	Enhancers	Fetal Muscle Leg	muscle
6	chr13:30962200-30964000	Enhancers	Fetal Stomach	stomach
7	chr13:30962200-30964000	Enhancers	Spleen	Spleen
8	chr13:30962200-30964200	Enhancers	Primary hematopoietic stem cells	blood
9	chr13:30962200-30964400	Enhancers	Primary hematopoietic stem cells short term culture	blood
10	chr13:30962200-30964400	Enhancers	Placenta	Placenta
11	chr13:30962400-30964000	Enhancers	NHLF	lung
12	chr13:30962400-30964200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
13	chr13:30962400-30964200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
14	chr13:30962600-30964000	Flanking Active TSS	Primary T cells from cord blood	blood
15	chr13:30962600-30964200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
16	chr13:30962600-30964200	Enhancers	HMEC	breast
17	chr13:30962600-30964400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
18	chr13:30962600-30964400	Flanking Active TSS	Dnd41	blood
19	chr13:30963000-30964000	Enhancers	HUES6 Cell Line	embryonic stem cell
20	chr13:30963000-30964000	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
21	chr13:30963000-30964000	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
22	chr13:30963000-30964000	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
23	chr13:30963000-30964000	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
24	chr13:30963000-30964000	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
25	chr13:30963000-30964000	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
26	chr13:30963000-30964000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
27	chr13:30963000-30964000	Flanking Active TSS	Colon Smooth Muscle	Colon
28	chr13:30963000-30964200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
29	chr13:30963000-30964200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
30	chr13:30963000-30964200	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
31	chr13:30963000-30964400	Enhancers	Placenta Amnion	Placenta Amnion
32	chr13:30963200-30964000	Enhancers	ES-I3 Cell Line	embryonic stem cell
33	chr13:30963200-30964000	Flanking Active TSS	Primary T helper memory cells from peripheral blood 2	blood
34	chr13:30963200-30964000	Flanking Active TSS	Primary T helper memory cells from peripheral blood 1	blood
35	chr13:30963200-30964000	Enhancers	Fetal Lung	lung
36	chr13:30963200-30964000	Flanking Active TSS	Fetal Thymus	thymus
37	chr13:30963200-30964000	Flanking Active TSS	Stomach Smooth Muscle	stomach
38	chr13:30963200-30964000	Flanking Active TSS	Thymus	Thymus
39	chr13:30963200-30964200	Flanking Active TSS	Primary T killer memory cells from peripheral blood	blood
40	chr13:30963200-30964200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
41	chr13:30963200-30964200	Enhancers	Fetal Kidney	kidney
42	chr13:30963200-30964200	Enhancers	Pancreatic Islets	Pancreatic Islet
43	chr13:30963200-30964200	Flanking Active TSS	HepG2	liver
44	chr13:30963400-30964000	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
45	chr13:30963400-30966400	Weak transcription	Fetal Muscle Trunk	muscle
46	chr13:30963600-30964200	Enhancers	Fetal Intestine Large	intestine
47	chr13:30963600-30964200	Enhancers	NHEK	skin
48	chr13:30963600-30964400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
49	chr13:30963600-30965800	Weak transcription	Fetal Brain Male	brain
50	chr13:30963800-30964000	Enhancers	HUES48 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links